WHO. World malaria report addressing inequity in the global malaria response. Geneva: World Health Organization; 2024. p. 2024.
Rosenthal PJ, Asua V, Bailey JA, Conrad MD, Ishengoma DS, Kamya MR, et al. The emergence of artemisinin partial resistance in Africa: how do we respond? Lancet Infect Dis. 2024;24:e591–600.
Google Scholar
Ishengoma DS, Mandara CI, Bakari C, Fola AA, Madebe RA, Seth MD, et al. Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance. Lancet Infect Dis. 2024;24:1225–33.
Google Scholar
Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960–6.
Google Scholar
van der Pluijm RW, Imwong M, Chau NH, Hoa NT, Thuy-Nhien NT, Thanh NV, et al. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study. Lancet Infect Dis. 2019;19:952–61.
Google Scholar
WHO. Malaria: Artemisinin partial resistance. Geneva: World Health Organization; 2025 [cited 2025 Jan 6]. Available from: https://www.who.int/news-room/questions-and-answers/item/artemisinin-resistance
Talisuna AO, Karema C, Ogutu B, Juma E, Logedi J, Nyandigisi A, et al. Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems. Lancet Infect Dis. 2012;12:888–96.
Google Scholar
Bwire GM, Ngasala B, Mikomangwa WP, Kilonzi M, Kamuhabwa AA. Detection of mutations associated with artemisinin resistance at k13-propeller gene and a near complete return of chloroquine susceptible falciparum malaria in Southeast of Tanzania. Sci Rep. 2020;10:3500.
Google Scholar
Juliano JJ, Giesbrecht DJ, Simkin A, Fola AA, Lyimo BM, Pereus D, et al. Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania. medRxiv. (preprint), 2023.
Thawer SG, Chacky F, Runge M, Reaves E, Mandike R, Lazaro S, et al. Sub-national stratification of malaria risk in mainland Tanzania: a simplified assembly of survey and routine data. Malar J. 2020;19:177.
Google Scholar
Conrad MD, Asua V, Garg S, Giesbrecht D, Niaré K, Smith S, et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N Engl J Med. 2023;389:722–32.
Google Scholar
Noviyanti R, Miotto O, Barry A, Marfurt J, Siegel S, Thuy-Nhien N, et al. Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region. Malar J. 2020;19:271.
Google Scholar
Sarah-Matio EM, Guillochon E, Nsango SE, Abate L, Ngou CM, Bouopda GA, et al. Genetic diversity of Plasmodium falciparum and distribution of antimalarial drug resistance mutations in symptomatic and asymptomatic infections. Antimicrob Agents Chemother. 2022;66: e0018822.
Google Scholar
He Q, Chaillet JK, Labbe F. Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance. Elife. 2024;12:RP90888.
Google Scholar
National Bureau of Statistics. National Climate Change Statistics Report, 2019, Tanzania Mainland. Dodoma, Tanzania; 2020.
WHO. Guidelines for malaria [Internet]. Geneva: World Health Organization; 2022 [cited 2025 Mar 13]. Available from: https://www.who.int/publications/i/item/guidelines-for-malaria
Koliopoulos P, Kayange NM, Daniel T, Huth F, Gröndahl B, Medina-Montaño GC, et al. Multiplex-RT-PCR-ELISA panel for detecting mosquito-borne pathogens: Plasmodium sp. preserved and eluted from dried blood spots on sample cards. Malar J. 2021;20:66.
Google Scholar
Snounou G. Genotyping of Plasmodium spp. nested PCR. Malar Methods Protoc. 2002;72:103–16.
Google Scholar
Some AF, Bazie T, Zongo I, Yerbanga RS, Nikiema F, Neya C, et al. Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso. Parasit Vectors. 2018;11:323.
Google Scholar
Aubouy A, Migot-Nabias F, Deloron P. Polymorphism in two merozoite surface proteins of Plasmodium falciparum isolates from Gabon. Malar J. 2003;2:12.
Google Scholar
Oboh MA, Ndiaye T, Diongue K, Ndiaye YD, Sy M, Deme AB, et al. Allelic diversity of MSP1 and MSP2 repeat loci correlate with levels of malaria endemicity in Senegal and Nigerian populations. Malar J. 2021;20:38.
Google Scholar
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.
Google Scholar
Li J, Chen J, Xie D, Monte-Nguba SM, Eyi JU, Matesa RA, et al. High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko Island. Equatorial Guinea Pathog Glob Health. 2014;108:339–43.
Google Scholar
StataCorp. Stata Statistical Software: Release 15. College Station (TX): StataCorp LLC; 2017.
R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2023. Available from: https://www.R-project.org/
Kang JM, Moon SU, Kim JY, Cho SH, Lin K, Sohn WM, et al. Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar. Malar J. 2010;9:131.
Google Scholar
Yakubu B, Longdet IY, Jen TH, Davou DT, Obishakin E. High-complexity Plasmodium falciparum infections, North Central Nigeria, 2015–2018. Emerg Infect Dis. 2019;25:1330–8.
Google Scholar
Bakari C, Mandara CI, Madebe RA, Seth MD, Ngasala B, Kamugisha E, et al. Trends of Plasmodium falciparum molecular markers associated with resistance to artemisinins and reduced susceptibility to lumefantrine in Mainland Tanzania from 2016 to 2021. Malar J. 2024;23:71.
Google Scholar
Uwimana A, Legrand E, Stokes BH, Ndikumana J-LM, Warsame M, Umulisa N, et al. Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda. Nat Med. 2020;26:1602–8.
Google Scholar
Ajogbasile FV, Oluniyi PE, Kayode AT, Akano KO, Adegboyega BB, Philip C, et al. Molecular profiling of the artemisinin resistance Kelch 13 gene in Plasmodium falciparum from Nigeria. PLoS ONE. 2022;17: e0264548.
Google Scholar
Boussaroque A, Fall B, Madamet M, Camara C, Benoit N, Fall M, et al. Emergence of mutations in the K13 propeller gene of Plasmodium falciparum isolates from Dakar, Senegal, in 2013–2014. Antimicrob Agents Chemother. 2015;60:624–7.
Google Scholar
Ndwiga L, Kimenyi KM, Wamae K, Osoti V, Akinyi M, Omedo I, et al. A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa. Int J Parasitol Drugs Drug Resist. 2021;16:155–61.
Google Scholar
WHO, Global Malaria Programme. Artemisinin and artemisinin-based combination therapy resistance [Internet]. Geneva: World Health Organization; 2016. Available from: https://www.who.int/publications/i/item/artemisinin-and-act-resistance
Wernsman Young N, Gashema P, Giesbrecht D, Munyaneza T, Maisha F, et al. High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing. J Infect Dis. 2025;231:269–80.
Google Scholar
Kakulu RK, Msuya MM, Makora SH, Lucas AM, Kapinga JV, Mwangoka NK, et al. Characterization of population connectivity for enhanced cross-border surveillance of yellow fever at Mutukula and Namanga borders in Tanzania. IJID Reg. 2024;13: 100476.
Google Scholar
Deane KD, Samwell Ngalya P, Boniface L, Bulugu G, Urassa M. Exploring the relationship between population mobility and HIV risk: evidence from Tanzania. Glob Public Health. 2018;13:173–88.
Google Scholar
Malmberg M, Ferreira PE, Tarning J, Ursing J, Ngasala B, Bjorkman A, et al. Plasmodium falciparum drug resistance phenotype as assessed by patient antimalarial drug levels and its association with pfmdr1 polymorphisms. J Infect Dis. 2013;207:842–7.
Google Scholar
Veiga MI, Dhingra SK, Henrich PP, Straimer J, Gnadig N, Uhlemann AC, et al. Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies. Nat Commun. 2016;7:11553.
Google Scholar
Okell LC, Reiter LM, Ebbe LS, Baraka V, Bisanzio D, Watson OJ, et al. Emerging implications of policies on malaria treatment: genetic changes in the Pfmdr-1 gene affecting susceptibility to artemether-lumefantrine and artesunate-amodiaquine in Africa. BMJ Glob Health. 2018;3: e000999.
Google Scholar
Marwa KJ, Lyimo E, Konje ET, Kapesa A, Kamugisha E, Swedberg G. Plasmodium falciparum merozoite surface proteins polymorphisms and treatment outcomes among patients with uncomplicated malaria in Mwanza, Tanzania. J Trop Med. 2022;2022:5089143.
Google Scholar
Sondo P, Derra K, Rouamba T, Nakanabo Diallo S, Taconet P, Kazienga A, et al. Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso. Parasit Vectors. 2020;13:427.
Google Scholar
Budodo R, Mandai SS, Bakari C, Seth MD, Francis F, Chacha GA, et al. Performance of rapid diagnostic tests, microscopy, and qPCR for detection of Plasmodium parasites among community members with or without symptoms of malaria in villages located in North-western Tanzania. Malar J. 2025;24:115.
Google Scholar
Mwesigwa A, Ocan M, Musinguzi B, Nante RW, Nankabirwa JI, Kiwuwa SM, et al. Plasmodium falciparum genetic diversity and multiplicity of infection based on msp-1, msp-2, glurp and microsatellite genetic markers in sub-Saharan Africa: a systematic review and meta-analysis. Malar J. 2024;23:97.
Google Scholar